Atlas Trials

Margaret Gatti-Mays

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Margaret Gatti-Mays

RecordFirmDate
Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer (NCT06026657)Margaret Gatti-Mays2024-04-02

Track Margaret Gatti-Mays automatically

Every clearance here is in the API, with alerts when new ones post.